Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ogoshi

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Cancer|June 1, 1994
Possible role of Helicobacter pylori infection in early gastric cancer developmentM Asaka, T Kimura, M Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer]T Sasaki, K Ota, J Ibayashi, et al.
European Journal of Gastroenterology & Hepatology|December 1, 1994
Helicobacter pylori infection in gastric carcinomaT Kato, Y Saito, M Niwa, et al.
Radiology|November 1, 1974
Endoscopic pancreatography: an analysis of the radiologic findings in pancreatitisA H Robbins, R A Messian, W C Widrich, et al.
Clinical Therapeutics|January 1, 1987
Postoperative intravenous administration of lysine acetylsalicylate: effect on pain relief and platelet functionH Hanaue, K Ogoshi, H Makuuchi, et al.
Nihon Gan Chiryo Gakkai Shi|July 20, 1990
[The effect of a protein-bound polysaccharide (PSK) on lymphocyte subsets of peripheral venous blood and thoracic duct lymph]H Hanaue, Y Tokuda, T Fujimoto, et al.
Clinical Therapeutics|September 1, 1989
Effects of oral lentinan on T-cell subsets in peripheral venous bloodH Hanaue, Y Tokuda, T Machimura, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2004
Helicobacter pylori infection in two areas in Japan with different risks for gastric cancerA Nobuta, M Asaka, T Sugiyama, et al.
The Tokai Journal of Experimental and Clinical Medicine|May 1, 1987
Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparationH Hanaue, D Y Kim, M Kubota, et al.
The Tokai Journal of Experimental and Clinical Medicine|November 1, 1987
Hemolytic streptococcus preparation OK-432; beneficial adjuvant therapy in recurrent gastric carcinomaH Hanaue, D Y Kim, T Machimura, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Cancer|June 1, 1994
Possible role of Helicobacter pylori infection in early gastric cancer developmentM Asaka, T Kimura, M Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer]T Sasaki, K Ota, J Ibayashi, et al.
European Journal of Gastroenterology & Hepatology|December 1, 1994
Helicobacter pylori infection in gastric carcinomaT Kato, Y Saito, M Niwa, et al.
Radiology|November 1, 1974
Endoscopic pancreatography: an analysis of the radiologic findings in pancreatitisA H Robbins, R A Messian, W C Widrich, et al.
Clinical Therapeutics|January 1, 1987
Postoperative intravenous administration of lysine acetylsalicylate: effect on pain relief and platelet functionH Hanaue, K Ogoshi, H Makuuchi, et al.
Nihon Gan Chiryo Gakkai Shi|July 20, 1990
[The effect of a protein-bound polysaccharide (PSK) on lymphocyte subsets of peripheral venous blood and thoracic duct lymph]H Hanaue, Y Tokuda, T Fujimoto, et al.
Clinical Therapeutics|September 1, 1989
Effects of oral lentinan on T-cell subsets in peripheral venous bloodH Hanaue, Y Tokuda, T Machimura, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2004
Helicobacter pylori infection in two areas in Japan with different risks for gastric cancerA Nobuta, M Asaka, T Sugiyama, et al.
The Tokai Journal of Experimental and Clinical Medicine|May 1, 1987
Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparationH Hanaue, D Y Kim, M Kubota, et al.
The Tokai Journal of Experimental and Clinical Medicine|November 1, 1987
Hemolytic streptococcus preparation OK-432; beneficial adjuvant therapy in recurrent gastric carcinomaH Hanaue, D Y Kim, T Machimura, et al.
Pageof 11